Bispecific T-Cell Engagers Market Insights Report (2026-2030) Featuring Strategic Analysis of Pfizer, Johnson & Johnson, Roche, AbbVie, Sanofi and Other Key Players [Yahoo! Finance]
Nasdaq, Inc. (NDAQ)
Last nasdaq, inc. earnings: 4/22 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.nasdaq.com
Company Research
Source: Yahoo! Finance
GlobeNewswire Inc. Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Bispecific T-Cell Engagers Market Report 2026" has been added to ResearchAndMarkets.com's offering. The bispecific T-cell engagers market is witnessing remarkable growth with projections showcasing a rise from $1.6 billion in 2025 to $1.94 billion by 2026, marking a CAGR of 21.3%. This trend is attributed to factors like limited efficacy of conventional cancer therapies, rising incidence of hematologic malignancies, breakthroughs in immune-oncology, and increased oncology research investments. Forecasts anticipate the market could reach $4.18 billion by 2030, sustaining a 21.2% CAGR, driven by technological advancements in antibody engineering, higher healthcare investments, and growing strategic partnerships. Bispecific T-cell engagers are crucial in the fight against cancer, particularly due to the rising global cancer incidence. The mechanism involves binding to both T cells and tumor cells, harnessing the im
Show less
Read more
Impact Snapshot
Event Time:
NDAQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NDAQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NDAQ alerts
High impacting Nasdaq, Inc. news events
Weekly update
A roundup of the hottest topics
NDAQ
News
- Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players [Yahoo! Finance]Yahoo! Finance
- Ascelia Pharma Announces Acceptance of Orviglance Data for Oral Presentation at the Annual Radiology Congress ESGAR 2026 [Yahoo! Finance]Yahoo! Finance
- Mount Sinai and Guyana Ministry of Health Launch National Initiative to Strengthen Hospital Quality and Patient Safety [Yahoo! Finance]Yahoo! Finance
- Black Rock Coffee Bar Continues Expansion in Colorado with New Colorado Springs Location [Yahoo! Finance]Yahoo! Finance
- TUK Group Advances $20 Million Toronto Development Pipeline and Expands Peterborough Portfolio [Yahoo! Finance]Yahoo! Finance
NDAQ
Earnings
- 1/29/26 - Beat
NDAQ
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/13/26 - Form 4
- 3/10/26 - Form 4
- NDAQ's page on the SEC website